Levocetirizine Dihydrochloride
Product Images NDC 63304-433

2 FDA label images from Ranbaxy Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 63304-433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ranbaxy Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 5mg (Image 01)

Bottle Label 5mg (Image 01)
Packaging label of Levocetirizine Dihydrochloride 5 mg tablets by Ranbaxy Pharmaceuticals Inc. The label shows the product name, strength, dosage form (tablets), and package size (10 tablets). It includes instructions for storage, tamper-resistant packaging, and a barcode. The product is for oral administration and is Rx only.*
FDA Label Image

Structure (Image 02)

Structure (Image 02)
Chemical structure of Levocetirizine Dihydrochloride, showing the molecular arrangement including chlorophenyl groups, piperazine ring, and carboxylic acid functional groups, along with the dihydrochloride moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.